Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system

Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system

ABSTRACT Human insulin is provided by the Brazilian Public Health System (BPHS) for the treatment of diabetes, however, legal proceedings to acquire insulin analogs have burdened the BPHS health system. The aim of this study was to perform a cost-effectiveness analysis to compare insulin analogs and...

Full description

Bibliographic Details
Main Authors: Maurílio de Souza Cazarim, João Paulo Vilela Rodrigues, Estael Luzia Coelho da Cruz-Cazarim, Lorena Rocha Ayres, Leonardo Régis Leira Pereira
Format: Article
Language:English
Published: Universidade de São Paulo 2017-11-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Diabetes Mellitus/treatment/cost-effectiveness/evaluation
Prolonged Action Insulin
Short Action Insulin
Brazilian Public Health System
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300616&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300616&lng=en&tlng=en

Similar Items